Evidence map›Paper›PMID 34009954›Full record

ArticleBioconjugate chemistry2021

Protocol for Creating Antibodies with Complex Fluorescence Spectra.

Madeline E McCarthy, Caitlin M Anglin, Heather A Peer, Sevanna A Boleman, Stephanie R Klaubert, Marc R Birtwistle

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Madeline E McCarthyDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.ORCID 0000-0002-6367-0461
Caitlin M AnglinDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.
Heather A PeerDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.
Sevanna A BolemanDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.
Stephanie R KlaubertDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.
Marc R BirtwistleDepartment of Chemical and Biomolecular Engineering, Clemson University, Clemson, South Carolina 29634, United States.ORCID 0000-0002-0341-0705

Funding

Mechanistic Pharmacodynamic Modeling for Drug Combination ResponsesR35GM141891 · NIGMS · CLEMSON UNIVERSITY · PI BIRTWISTLE, MARC R. · 2021 to 2025
$2.1M
Multiplexed, Quantitative Fluorescence Imaging in Tumor SectionsR21CA196418 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIRTWISTLE, MARC R. · 2015 to 2017
$936k
NCI NIH HHS R21 CA196418NIGMS NIH HHS R35 GM141891
6 · The paper itself

Abstract

Fluorescent antibodies are a workhorse of biomedical science, but fluorescence multiplexing has been notoriously difficult due to spectral overlap between fluorophores. We recently established proof-of-principal for fluorescence Multiplexing using Spectral Imaging and Combinatorics (MuSIC), which uses combinations of existing fluorophores to create unique spectral signatures for increased multiplexing. However, a method for labeling antibodies with MuSIC probes has not yet been developed. Here, we present a method for labeling antibodies with MuSIC probes. We conjugate a DBCO-Peg5-NHS ester linker to antibodies and a single-stranded DNA "docking strand" to the linker and, finally, hybridize two MuSIC-compatible, fluorescently labeled oligos to the docking strand. We validate the labeling protocol with spin-column purification and absorbance measurements. We demonstrate the approach using (i) Cy3, (ii) Tex615, and (iii) a Cy3-Tex615 combination as three different MuSIC probes attached to three separate batches of antibodies. We created single-, double-, and triple-positive beads that are analogous to single cells by incubating MuSIC probe-labeled antibodies with protein A beads. Spectral flow cytometry experiments demonstrate that each MuSIC probe can be uniquely distinguished, and the fraction of beads in a mixture with different staining patterns are accurately inferred. The approach is general and might be more broadly applied to cell-type profiling or tissue heterogeneity studies in clinical, biomedical, and drug discovery research.

Indexed as

AntibodiesDNA, Single-StrandedMolecular Docking SimulationNucleic Acid ConformationProtein ConformationSpectrometry, FluorescenceAntibodiesDNA, Single-Stranded

Identifiers

PMID34009954
PMCPMC8845489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.